Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ¥193,546.29, with a 24-hour trading volume of ¥373.77B. The asset's market cap is ¥172.59T, after moving -0.09% in the last day.
Tokenized Eli Lilly And Co is trading at ¥194,046.69, with a tokenized market cap of ¥7.67B and a 24-hour trading volume of ¥362.05M. The tokenized asset has moved 0.92% in the past 24 hours.